Staffan Encrantz is Director & 10% Owner at Sight Sciences, Inc. (SGHT). They have made 15 open-market trades across 1 company since 2021, most recently 2026-06-10.
CIK 0001870875
14 open-market purchases totalling $51.8M since 2021, against 1 sale. Across 14 scored buys the stock is up 14.1% at ninety days, and 8.2 points ahead of the S&P over the same stretch.
14 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| SGHT | 1,434,283 | $11.9M |
Shares reported on the most recent Form 4, priced at the 2026-06-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 64% | 57% | 50% |
| Avg Move | +7.4% | +11.8% | +14.1% |
| Alpha | +6.1% | +9.3% | +8.2% |
| Scored | 14 | 14 | 14 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGHT | BUY | 2026-06-10 | 2026-06-11 | $4.88 | $69K | +10.6% | +7.0% | +61.5% |
| SGHT | BUY | 2025-12-16 | 2025-12-18 | $8.31 | $232K | -5.0% | -25.3% | -55.8% |
| SGHT | BUY | 2025-06-04 | 2025-06-06 | $4.22 | $646K | +0.5% | -18.2% | -12.2% |
| SGHT | BUY | 2025-05-30 | 2025-06-03 | $3.81 | $753K | +2.0% | +4.0% | -4.4% |
| SGHT | BUY | 2025-05-27 | 2025-05-29 | $3.53 | $904K | +14.2% | +13.2% | +15.9% |
| SGHT | SELL | 2024-11-21 | 2024-11-21 | $3.73 | $2.1M | -6.7% | -12.9% | -31.0% |
| SGHT | BUY | 2024-11-21 | 2024-11-21 | $3.73 | $4.1M | -6.7% | -12.9% | -31.0% |
| SGHT | BUY | 2023-11-29 | 2023-12-01 | $3.46 | $985K | +3.3% | +67.2% | +31.8% |
| SGHT | BUY | 2023-11-24 | 2023-11-28 | $3.37 | $3.5M | -22.4% | +49.5% | +20.8% |
| SGHT | BUY | 2023-11-20 | 2023-11-22 | $2.39 | $902K | +7.5% | +36.8% | +56.0% |
| SGHT | BUY | 2023-11-16 | 2023-11-20 | $2.19 | $555K | +19.3% | +37.0% | +70.8% |
| SGHT | BUY | 2023-11-14 | 2023-11-16 | $2.00 | $7K | +77.4% | +58.2% | +105.8% |
| SGHT | BUY | 2022-05-13 | 2022-05-17 | $8.33 | $4.6M | -1.7% | -16.3% | -2.1% |
| SGHT | BUY | 2021-11-29 | 2021-12-01 | $20.90 | $21.9M | -3.7% | -17.0% | -17.7% |
| SGHT | BUY | 2021-10-18 | 2021-10-20 | $24.00 | $12.6M | +9.0% | -17.4% | -41.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.